[1] WANG Y, WANG Y, LI K, et al. An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors[J]. Bioscience Reports, 2020, 40(10):BSR20202338. [2] BLENCOWE B J.The relationship between alternative splicing and proteomic complexity[J]. Trends in Biochemical Sciences, 2017, 42(6):407-408. [3] ZHAO S.Alternative splicing, RNA-seq and drug discovery[J]. Drug Discovery Today, 2019, 24(6):1258-1267. [4] BARALLE F E, GIUDICE J.Alternative splicing as a regulator of development and tissue identity[J]. Nature Reviews.Molecular Cell Biology, 2017, 18(7):437-451. [5] KIM H K, PHAM M, KO K S, et al. Alternative splicing isoforms in health and disease[J]. Pflugers Archiv:European Journal of Physiology, 2018, 470(7):995-1016. [6] XU B, SHI Y, WU Y, et al. Role of RNA secondary structures in regulating Dscam alternative splicing[J]. Biochimica et Biophysica Acta, 2019, 1862(11-12):194381. [7] JIN Y, DONG H, SHI Y, et al. Mutually exclusive alternative splicing of pre-mRNAs[J]. Wiley Interdisciplinary Reviews.RNA, 2018, 9(3):e1468. [8] PLASCHKA C, LIN P C, CHARENTON C, et al. Prespliceosome structure provides insights into spliceosome assembly and regulation[J]. Nature, 2018, 559(7714):419-422. [9] FISZBEIN A, KRICK K S, BEGG B E, et al. Exon-mediated activation of transcription starts[J]. Cell, 2019, 179(7):1551-1565. [10] WANG Y, LIU J, HUANG B O, et al. Mechanism of alternative splicing and its regulation[J]. Biomedical Reports, 2015, 3(2):152-158. [11] CHEN M, MANLEY J L.Mechanisms of alternative splicing regulation:Insights from molecular and genomics approaches[J]. Nature Reviews.Molecular Cell Biology, 2009, 10(11):741-754. [12] BAEZA-CENTURION P, MINANA B, VALCARCEL J, et al. Mutations primarily alter the inclusion of alternatively spliced exons[J]. eLife, 2020, 9:e59959. [13] RONG S, BUERER L, RHINE C L, et al. Mutational bias and the protein code shape the evolution of splicing enhancers[J]. Nature Communications, 2020, 11(1):2845. [14] CHEN S Y, LI C, JIA X, et al. Sequence and evolutionary features for the alternatively spliced exons of eukaryotic genes[J]. International Journal of Molecular Sciences, 2019, 20(15):3834. [15] ROGERS S O.Integrated evolution of ribosomal RNAs, introns, and intron nurseries[J]. Genetica, 2019, 147(2):103-119. [16] MOVASSAT M, FOROUZMAND E, REESE F, et al. Exon size and sequence conservation improves identification of splice-altering nucleotides[J]. RNA, 2019, 25(12):1793-1805. [17] GONZALEZ-HILARION S, PAULET D, LEE K T, et al. Intron retention-dependent gene regulation in Cryptococcus neoformans[J]. Scientific Reports, 2016, 6:32252. [18] POVERENNAYA I V, ROYTBERG M A.Spliceosomal introns:Features, functions, and evolution[J]. Biochemistry.Biokhimiia, 2020, 85(7):725-734. [19] KEDZIERSKA H, PIEKIELKO-WITKOWSKA A.Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer[J]. Cancer letters, 2017, 396:53-65. [20] YANG Q, ZHAO J, ZHANG W, et al. Aberrant alternative splicing in breast cancer[J]. Journal of Molecular Cell Biology, 2019, 11(10):920-929. [21] MELO J P, KALYNA M, DUQUE P.Current challenges in studying alternative splicing in plants:The case of physcomitrella patens SR proteins[J]. Frontiers in Plant Science, 2020, 11:286. [22] THIJSSEN V L, HEUSSCHEN R, CAERS J, et al. Galectin expression in cancer diagnosis and prognosis:A systematic review[J]. Biochimica et Biophysica Acta, 2015, 1855(2):235-247. [23] SAHEBI M, HANAFI M M, VAN WIJNEN A J, et al. Towards understanding pre-mRNA splicing mechanisms and the role of SR proteins[J]. Gene, 2016, 587(2):107-119. [24] WANG Z, XIAO X, VAN NOSTRAND E, et al. General and specific functions of exonic splicing silencers in splicing control[J]. Molecular Cell, 2006, 23(1):61-70. [25] STEVENS M, OLTEAN S.Modulation of the apoptosis gene Bcl-x function through alternative splicing[J]. Frontiers in Genetics, 2019, 10:804. [26] DA S M, MOREIRA G A, GONCALVES D S R, et al. Splicing regulators and their roles in cancer biology and therapy[J]. BioMed Research International, 2015, 2015:150514. [27] LONG Y, SOU W H, YUNG K, et al. Distinct mechanisms govern the phosphorylation of different SR protein splicing factors[J]. The Journal of Biological Chemistry, 2019, 294(4):1312-1327. [28] DESCHENES M, CHABOT B.The emerging role of alternative splicing in senescence and aging[J]. Aging Cell, 2017, 16(5):918-933. [29] URBANSKI L M, LECLAIR N, ANCZUKOW O.Alternative-splicing defects in cancer:Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics[J]. Wiley Interdisciplinary Reviews.RNA, 2018, 9(4):e1476. [30] GEORGE A, AUBOL B E, FATTET L, et al. Disordered protein interactions for an ordered cellular transition:Cdc2-like kinase 1 is transported to the nucleus via its Ser-Arg protein substrate[J]. The Journal of Biological Chemistry, 2019, 294(24):9631-9641. [31] SAVISAAR R, HURST L D.Purifying selection on exonic splice enhancers in intronless genes[J]. Molecular Biology and Evolution, 2016, 33(6):1396-1418. [32] NTINI E, MARSICO A.Functional impacts of non-coding RNA processing on enhancer activity and target gene expression[J]. Journal of Molecular Cell Biology, 2019, 11(10):868-879. [33] AOYAMA Y, SASAI H, ABDELKREEM E, et al. A novel mutation (c.12113 T>A) in the polypyrimidine tract of the splice acceptor site of intron 2 causes exon 3 skipping in mitochondrial acetoacetyl-CoA thiolase gene[J]. Molecular Medicine Reports, 2017, 15(6):3879-3884. [34] GUEROUSSOV S, WEATHERITT R J, O'HANLON D, et al. Regulatory expansion in mammals of multivalent hnRNP assemblies that globally control alternative splicing[J]. Cell, 2017, 170(2):324-339. [35] YING Y, WANG X, VUONG C K, et al. Splicing activation by Rbfox requires self-aggregation through its tyrosine-rich domain[J]. Cell, 2017, 170(2):312-323. [36] SUN W, HU S, HU J, et al. Akirin 1 promotes myoblast differentiation by modulating multiple myoblast differentiation factors[J]. Bioscience Reports, 2019, 39(3):BSR20182152. [37] 易茜.IGF1剪接变异体IGF1Ec对成肌细胞生物学功能的影响及相关机理研究[D].重庆:重庆大学, 2016. YI Q.Effect of IGF1 splicing isoform IGF1Ec on the biological function of myoblasts and its related mechanism[D].Chongqing:Chongqing University, 2016.(in Chinese) [38] HU J, QIAN H, XUE Y, et al. PTB/nPTB:Master regulators of neuronal fate in mammals[J]. Biophysics Reports, 2018, 4(4):204-214. [39] GRABOWSKI P J, BLACK D L.Alternative RNA splicing in the nervous system[J]. Progress in Neurobiology, 2001, 65(3):289-308. [40] LE SOMMER C, LESIMPLE M, MEREAU A, et al. PTB regulates the processing of a 3'-terminal exon by repressing both splicing and polyadenylation[J]. Molecular and Cellular Biology, 2005, 25(21):9595-9607. [41] GOODING C, ROBERTS G C, SMITH C W.Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon[J]. RNA, 1998, 4(1):85-100. [42] LÓPEZ-MARTÍNEZ A, SOBLECHERO-MARTÍN P, DE-LA-PUENTE-OVEJERO L, et al. An overview of alternative splicing defects implicated in myotonic dystrophy type Ⅰ[J]. Genes, 2020, 11(9):1109. [43] GAZZARA M R, MALLORY M J, ROYTENBERG R, et al. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes[J]. Genome Research, 2017, 27(8):1360-1370. [44] SUREAU A, SAULIERE J, EXPERT-BEZANCON A, et al. CELF and PTB proteins modulate the inclusion of the beta-tropomyosin exon 6B during myogenic differentiation[J]. Experimental Cell Research, 2011, 317(1):94-106. [45] LIN J C, YAN Y T, HSIEH W K, et al. RBM4 promotes pancreas cell differentiation and insulin expression[J]. Molecular and Cellular Biology, 2013, 33(2):319-327. [46] SU C H, HUNG K Y, HUNG S C, et al. RBM4 regulates neuronal differentiation of mesenchymal stem cells by modulating alternative splicing of pyruvate kinase M[J]. Molecular and Cellular Biology, 2017, 37(3):e00466-16. [47] LU C C, CHEN T H, WU J R, et al. Phylogenetic and molecular characterization of the splicing factor RBM4[J]. PLoS One, 2013, 8(3):e59092. [48] YANG J, HUNG L H, LICHT T, et al. RBM24 is a major regulator of muscle-specific alternative splicing[J]. Developmental Cell, 2014, 31(1):87-99. [49] LIN J C, TARN W Y.RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing[J]. The Journal of Cell Biology, 2011, 193(3):509-520. [50] TAMURA Y.Cross-bridge mechanism of residual force enhancement after stretching in a skeletal muscle[J]. Computer Methods in Biomechanics and Biomedical Engineering, 2018, 21(1):75-82. [51] ABOELKASSEM Y, TRAYANOVA N.Tropomyosin dynamics during cardiac muscle contraction as governed by a multi-well energy landscape[J]. Progress in Biophysics and Molecular Biology, 2019, 144:102-115. [52] YAMADA Y, NAMBA K, FUJII T.Cardiac muscle thin filament structures reveal calcium regulatory mechanism[J]. Nature Communications, 2020, 11(1):153. [53] ZHU Y, ZHANG J W, QI J, et al. Molecular regulation mechanism of Myomaker and Myomerger in myoblast fusion[J]. Yi Chuan, 2019, 41(12):1110-1118. [54] 孔旭.Rbm24调控心脏肌节组装及与心肌病关系的研究[D].厦门:厦门大学, 2018. KONG X.Rbm24 modulated cardiac segmental assembly and its relationship with cardiomyopathy[D].Xiamen:Xiamen University, 2018.(in Chinese) [55] LAAKSO J M, LEWIS J H, SHUMAN H, et al. Control of myosin-Ⅰ force sensing by alternative splicing[J]. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(2):698-702. [56] GHALEB A M, BIALKOWSKA A B, SNIDER A J, et al. IQ motif-containing GTPase-activating protein 2(IQGAP2) is a novel regulator of colonic inflammation in mice[J]. PLoS One, 2015, 10(6):e129314. [57] SUGI H, CHAEN S, AKIMOTO T.Electron microscopic recording of the power and recovery strokes of individual myosin heads coupled with ATP hydrolysis:Facts and implications[J]. International Journal of Molecular Sciences, 2018, 19(5):1368. [58] GALLEGO M E, SIRAND-PUGNET P, DUROSAY P, et al. Tissue-specific splicing of two mutually exclusive exons of the chicken beta-tropomyosin pre-mRNA:Positive and negative regulations[J]. Biochimie, 1996, 78(6):457-465. [59] GALLEGO M E, BALVAY L, BRODY E.cis-acting sequences involved in exon selection in the chicken beta-tropomyosin gene[J]. Molecular and Cellular Biology, 1992, 12(12):5415-5425. [60] LIBRI D, GOUX-PELLETAN M, BRODY E, et al. Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene[J]. Molecular and Cellular Biology, 1990, 10(10):5036-5046. [61] GALLEGO M E, GATTONI R, STEVENIN J, et al. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A[J]. The EMBO Journal, 1997, 16(7):1772-1784. [62] EXPERT-BEZANCON A, SUREAU A, DUROSAY P, et al. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B[J]. The Journal of Biological Chemistry, 2004, 279(37):38249-38259. [63] BAREJA A, HOLT J A, LUO G, et al. Human and mouse skeletal muscle stem cells:Convergent and divergent mechanisms of myogenesis[J]. PLoS One, 2014, 9(2):e90398. [64] NIKONOVA E, KAO S Y, RAVICHANDRAN K, et al. Conserved functions of RNA-binding proteins in muscle[J]. The International Journal of Biochemistry & Cell Biology, 2019, 110:29-49. [65] CHARLESTON J S, SCHNELL F J, DWORZAK J, et al. Eteplirsen treatment for Duchenne muscular dystrophy:Exon skipping and dystrophin production[J]. Neurology, 2018, 90(24):e2146-e2154. [66] RODRIGUEZ J M, POZO F, DI DOMENICO T, et al. An analysis of tissue-specific alternative splicing at the protein level[J]. PLoS Computational Biology, 2020, 16(10):e1008287. [67] NAKKA K, GHIGNA C, GABELLINI D, et al. Diversification of the muscle proteome through alternative splicing[J]. Skelet Muscle, 2018, 8(1):8. [68] NIKONOVA E, KAO S Y, SPLETTER M L.Contributions of alternative splicing to muscle type development and function[J]. Seminars in Cell & Developmental Biology, 2020, 104:65-80. [69] REISER P J, MOSS R L, GIULIAN G G, et al. Shortening velocity in single fibers from adult rabbit soleus muscles is correlated with myosin heavy chain composition[J]. The Journal of Biological Chemistry, 1985, 260(16):9077-9080. [70] ANDERSON R L, TRIVEDI D V, SARKAR S S, et al. Deciphering the super relaxed state of human beta-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers[J]. Proceedings of the National Academy of Sciences of the United States of America, 2018, 115(35):E8143-E8152. [71] KRONERT W A, MELKANI G C, MELKANI A, et al. Alternative relay and converter domains tune native muscle myosin isoform function in Drosophila[J]. Journal of Molecular Biology, 2012, 416(4):543-557. [72] YANG C, KAPLAN C N, THATCHER M L, et al. The influence of myosin converter and relay domains on cross-bridge kinetics of Drosophila indirect flight muscle[J]. Biophysical Journal, 2010, 99(5):1546-1555. [73] MILLER B M, BLOEMINK M J, NYITRAI M, et al. A variable domain near the ATP-binding site in Drosophila muscle myosin is part of the communication pathway between the nucleotide and actin-binding sites[J]. Journal of Molecular Biology, 2007, 368(4):1051-1066. [74] PANDEY M, STORMO G D, DUTCHER S K.Alternative splicing during the Chlamydomonas reinhardtii cell cycle[J]. G3(Bethesda), 2020, 10(10):3797-3810. [75] YANG M, SHANG X, ZHOU Y, et al. Full-length transcriptome analysis of Plasmodium falciparum by single-molecule long-read sequencing[J]. Frontiers in Cellular and Infection Microbiology, 2021, 11:631545. [76] FAIGENBLOOM L, RUBINSTEIN N D, KLOOG Y, et al. Regulation of alternative splicing at the single-cell level[J]. Molecular Systems Biology, 2015, 11(12):845. [77] TSAO A E, EDDINGER T J.Smooth muscle myosin heavy chains combine to form three native myosin isoforms[J]. The American Journal of Physiology, 1993, 264(5 Pt2):H1653-H1662. [78] EDDINGER T J, KORWEK A A, MEER D P, et al. Expression of smooth muscle myosin light chain 17 and unloaded shortening in single smooth muscle cells[J]. American Journal of Physiology.Cell Physiology, 2000, 278(6):C1133-C1142. |